Peptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brain

Agriculture & Biology

• cisplatin 100%
• methotrexate 99%
• brain 53%
• peptides 52%
• blood-brain barrier 40%
• brain neoplasms 23%
• nervous system diseases 20%
• clinical examination 17%
• injection 15%
• ligands 13%
• dyes 12%
• therapeutics 11%
• receptors 10%
• drugs 10%
• uptake mechanisms 10%
• synthetic peptides 8%
• blue light 8%
• intravenous injection 7%
• thighs 7%
• insulin 6%
• permeability 6%
• methodology 6%
• proteins 2%

Chemical Compounds

• Methotrexate 96%
• Cisplatin 83%
• Peptide 44%
• Antineoplastic Agent 34%
• Disorder 32%
• Intracranial 30%
• Evans Blue 30%
• Dye 23%
• Light Green 23%
• Drug 20%
• Molecule 19%
• Insulin Derivative 19%
• Permeability 15%
• Modification 10%
• Mixture 8%
• Protein 7%

Medicine & Life Sciences

• Methotrexate 74%
• Cisplatin 69%
• Peptides 49%
• Brain 37%
• Blood-Brain Barrier 29%
• Light green SF 16%
• Nervous System Diseases 14%
• Brain Neoplasms 14%
• Injections 13%
• Coloring Agents 12%
• Ligands 10%
• Evans Blue 9%
• Cetuximab 9%
• Drug Carriers 9%
• Femoral Vein 9%
• Intravenous Injections 7%
• Permeability 6%
• Carrier Proteins 6%
• Insulin 5%
• Pharmaceutical Preparations 3%
• Therapeutics 2%